XCiDaBLE: Observational, prospective trial evaluating xeomin (incobotulinumtoxinA) for cervical dystonia or blepharospasm in the USA

被引：0

|

作者：

Fernandez, H. H.

Jankovic, J.

Pagan, F.

Greeley, D.

Sethi, K.

Verma, A.

机构：

来源：

MOVEMENT DISORDERS | 2015年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1305

引用

收藏

页码：S508 / S508

页数：1

相关论文

共 50 条

[31] Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
Kent, Ruth
Robertson, Adrian
Quinones Aguilar, Sandra
Tzoulis, Charalampos
Maltman, John
TOXINS, 2021, 13 (07)
[32] Clinical Improvement After Treatment With IncobotulinumtoxinA (XEOMIN®) in Patients With Cervical Dystonia Resistant to Botulinum Toxin Preparations Containing Complexing Proteins
Hefter, Harald
Hartmann, Christian J.
Kahlen, Ulrike
Samadzadeh, Sara
Rosenthal, Dietmar
Moll, Marek
FRONTIERS IN NEUROLOGY, 2021, 12
[33] Cost-utility analysis of flexible interval incobotulinumtoxinA versus onabotulinumtoxinA in the management of blepharospasm and cervical dystonia in Ontario, Canada.
Gendron, M. E.
Gendron, M. E.
Kazerooni, R.
MOVEMENT DISORDERS, 2017, 32
[34] IncobotulinimtoxinA (Xeomin) for the treatment of adductor laryngeal dystonia: A prospective, open-label clinical trial
Kohli, Nikita
Lerner, Michael
Rashty, Jamie
Kirke, Diana
Stewart, Thomas
Blitzer, Andrew
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2022, 43 (06)
[35] IncobotulinumtoxinA (Xeomin®) Remains Well Tolerated across Flexible Inter-Injection Intervals of 6-20 Weeks in the Treatment of Cervical Dystonia
Fernandez, Hubert
Truong, Daniel
Asmus, Friedrich
Hanschmann, Angelika
LeDoux, Mark
NEUROLOGY, 2012, 78
[36] Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
Gendron, M. E.
Kazerooni, R.
Vezina, D.
MOVEMENT DISORDERS, 2020, 35 : S132 - S132
[37] The effect of botulinum toxin on anxiety in cervical dystonia: A prospective, observational study
Sugar, Dana
Patel, Roshni
Comella, Cynthia
Gonzalez, David A.
Gray, Gabrielle
Stebbins, Glenn T.
Mahajan, Abhimanyu
PARKINSONISM & RELATED DISORDERS, 2023, 114
[38] Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
Gendron, Marie-Eve
Kazerooni, Rashid
Vezina, Denis
NEUROLOGY, 2021, 96 (15)
[39] Cost-Utility Analysis of Flexible Intervals with IncobotulinumtoxinA Versus Fixed Dosing with OnabotulinumtoxinA in the Management of Cervical Dystonia and Blepharospasm in Major Canadian Markets
Gendron, Marie-Eve
Kazerooni, Rashid
Vezina, Denis
NEUROLOGY, 2020, 94 (15)
[40] COST-UTILITY ANALYSIS OF FLEXIBLE INTERVALS WITH INCOBOTULINUMTOXINA VERSUS FIXED DOSING WITH ONABOTULINUMTOXINA IN THE MANAGEMENT OF CERVICAL DYSTONIA AND BLEPHAROSPASM IN FOUR MAJOR CANADIAN PROVINCES
Gendron, Marie-Eve
Kazerooni, Rashid
Vezina, Denis
TOXICON, 2021, 190 : S27 - S27

← 1 2 3 4 5 →